Comprehensive analysis of the implementation of automatic control system in pharmaceutical factories

In the pharmaceutical industry, automatic control systems have long gone beyond simple temperature control. They are directly related to drug quality, production compliance and operational efficiency. Faced with increasingly strict regulatory requirements such as GMP and FDA, as well as the booming biomedical industry in central and southwest China, how to build a "compliant, reliable and efficient" automatic control system has become a key challenge for new construction or transformation projects of pharmaceutical companies. Based on the special needs of the pharmaceutical industry and combined with Shanghai Ruikongyuan Intelligent Technology Co., Ltd.'s practical experience in serving many pharmaceutical companies, this paper will deeply analyze the core steps, common misunderstandings and success keys in the implementation of the automatic control system, and provide a detailed "roadmap" for your project decision-making.

** Step 1: Requirements analysis and compliance design (foundation laying stage, key to avoiding pitfalls)**
Myth: Go directly to equipment selection and ignore user requirements specifications (URS) and compliance design based on risk assessment.
Analysis: It all starts with a detailed and accurate User Requirements Description (URS). This document should be jointly formulated by multiple departments such as production, quality, equipment, and engineering to clarify all process parameters that the system needs to control (such as fermentation tank temperature, pH value, clean room pressure difference, sterilization cabinet temperature curve), data recording and Alarm requirements, user authority levels, etc.
In the early stages of the project start-up, Ruikongyuan will send engineers with both self-control technology and GMP knowledge to work with the customer team to polish the URS to ensure that requirements are unambiguous and verifiable. More importantly, a system impact assessment (SIA) and component criticality assessment (CCA) are carried out based on URS to determine which critical systems and components are that directly affect product quality, so as to allocate appropriate verification energy and control strategies during the design stage. This is fundamental to meeting regulatory requirements such as data integrity (ALCOA+ principles) and 21 CFR Part 11.

** Step 2: Supplier selection and technical plan evaluation (decision-making stage, where the value lies)**
Myth: Only price theory, or only value hardware brands, ignoring suppliers 'industry experience, verification support capabilities and long-term service capabilities.
Analysis: Suppliers of pharmaceutical automatic control systems must be partners who "understand the industry". The evaluation dimensions should include at least:
1. ** Industry cases and compliance experience **: Are there successful cases of similar dosage forms (such as sterile preparations, biological products, and APIs)? Can you provide a complete verification document template (e.g. IQ/OQ/PQ protocol) reference? Ruikongyuan has accumulated rich experience from BMS (Building Management System) to EMS (Environmental Monitoring System) and PCS (Process Control System) in multiple pharmaceutical projects in the Yangtze River Delta and Central China.
2. ** Compliance and reliability of technical solutions **: Does the system architecture meet redundancy requirements? Are audit trails, electronic signatures, data backup and recovery mechanisms compliant with regulations? Do you use mainstream hardware platforms such as Siemens and Rockwell that have been verified by a large number of pharmaceutical companies? As a partner of many internationally renowned automation brands, Ruikongyuan can ensure the reliability and compliance foundation of the hardware platform.
3. ** Verification support service capabilities **: Do you have full-time or experienced verification support personnel? Can you assist customers through the entire process from Verification Plan (VP) to Verification Summary Report (VSR)? This is the core that distinguishes ordinary integrators from professional pharmaceutical company service providers. Ruikongyuan's technical team is well versed in the verification process and can efficiently collaborate to accelerate the project compliance process.
4. ** Localized Service and Incident Response Service **: Pharmaceutical factory production cannot be interrupted for a long time. Does the supplier have a fast-response service network in the project location (such as southwest and south China)? The layout of key areas across the country of Ruikongyuan ensures the timeliness of services.

** Step 3: Project implementation and verification execution (implementation stage, quality core)**
Misunderstanding: Construction and verification are disconnected, and debugging is insufficient, resulting in later verification failures or frequent operation failures.
Analysis: This stage requires close collaboration between customers, suppliers (Ruikongyuan), and third-party verification companies (if any).
- ** Deepen design and FAT (Factory Acceptance Test)**: Deepen the design based on the final URS and generate detailed design instructions. It is crucial to carry out FAT before equipment leaves the factory. Ruikongyuan will build a simulation environment in its factory or debugging center, work with customers to check hardware functions, software logic and basic operations according to predetermined test plans, discover and solve problems in advance, and avoid the high cost of on-site rectification.
- ** On-site installation and SAT (On-site Acceptance Test)/IQ/OQ**: On-site installation must follow established construction specifications. After the installation is completed, perform SAT to confirm that the equipment functions normally after transportation and installation. Subsequently, it officially entered the verification stage: Installation Qualification (IQ) checks whether the installation meets the design specifications; Operation Qualification (OQ) tests whether the system functions meet URS requirements, where various normal and extreme working conditions need to be simulated. Ruikongyuan engineers will participate in the entire process and provide technical support to ensure the smooth progress of the test.
- ** Commissioning and commissioning **: After OQ and before PQ (Performance Qualification), sufficient commissioning and commissioning should be carried out with or without materials to further optimize control parameters and train operators. Ruikang will provide system operation and maintenance training and deliver a complete as-built document package.

** Step 4: System operation and maintenance and continuous improvement (long-term phase, value extension)**
Myth: After project acceptance, supplier support is terminated, the system gradually becomes a "black box", changes are out of control, and compliance risks accumulate.
Analysis: The life cycle of the automatic control system lasts for more than ten years, and operation and maintenance are equally important as continuous improvement.
- ** Preventive maintenance and calibration **: Develop and implement regular calibration plans for key instruments (such as temperature and pressure sensors) to carry out preventive maintenance on controllers and servers. Ruikongyuan can provide customized maintenance service contracts, including regular inspections, spare parts support and technical consultation.
- ** Change management and system upgrade **: Any modifications to the system (such as program modifications, hardware replacements) must follow strict change control processes and undergo corresponding re-verification. As the original system builder, Ruikongyuan can provide the most professional and efficient change support services to ensure that the system remains compliant and stable after changes.
- ** Data analysis and energy efficiency improvement **: Use historical system data to analyze energy consumption bottlenecks and equipment operating efficiency to provide a basis for continuous process improvement and energy conservation and consumption reduction. Ruikongyuan's energy management solutions can be seamlessly integrated to help pharmaceutical companies achieve green operations while ensuring compliance.

** Successful practice and value implantation of Ruikongyuan **
In the expansion project of a well-known biopharmaceutical company in Central China, Ruikongyuan undertook the construction of BMS and EMS systems in its core production workshop. The project faces challenges of high cleanliness level, complex processes, and strict verification requirements. The Ruikongyuan team ensured success with the following key actions:
1. ** In-depth intervention in the early stage **: Working with the customer quality department to improve the URS and clarify the alarm classification and data recording frequency of hundreds of monitoring points.
2. ** Compliance design **: Adopt a highly reliable hardware platform and design a complete audit trail and data backup solution to meet data integrity requirements from the source.
3. ** Efficient verification collaboration **: The draft standardized verification document provided by Ruikongyuan greatly improves the efficiency of the customer verification team. More than ten potential problems were discovered and solved during the FAT stage, ensuring on-site progress.
4. ** Long-term service support **: After the project was delivered, Ruikongyuan provided three-year maintenance services and assisted customers in completing system modifications and re-verifications related to multiple process changes, becoming a long-term technical partner trusted by customers.

** Conclusion **
The construction of automatic control systems in pharmaceutical factories is a precision project related to "quality" and "compliance". Choosing a partner like Shanghai Ruikongyuan that has deep industry knowledge, solid technical implementation capabilities, improved verification support systems and reliable long-term service commitments is the best decision to avoid project risks and ensure compliance and efficient operation throughout the system life cycle. From URS to verification, from operation and maintenance to upgrade, Ruikongyuan is committed to building a solid and reliable automation foundation for your drug safety production with professional and efficient localized services.